CRISPR iPSC Retinal Ganglion Cell Differentiation Without Lentiviral Vectors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) face challenges such as limited efficiency, precision, scalability, and safety concerns, particularly due to the use of lentiviral vectors and reliance on endpoint analyses that lack real-time monitoring.
Innovation Solution
A method involving CRISPR editing to delete the LNC000093 long non-coding RNA sequence, followed by culturing iPSC colonies to form embryoid bodies, inducing neural rosettes, and differentiating into RGCs through neurospheres, with validation using RGC-specific markers and single-cell RNA sequencing, and optionally enriching the population using MACS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If lentiviral transduction is used to overexpress NGN2 for RGC differentiation, then differentiation efficiency is improved, but safety concerns and off-target effects increase
Solution Approach 1:
The patent extracts and removes the harmful lentiviral vector system from the differentiation protocol, replacing it with CRISPR-Cas9-mediated knockout of the LINC000093 long non-coding RNA. This eliminates the safety concerns and off-target effects associated with viral transduction while maintaining differentiation efficiency through precise genetic manipulation of the target lncRNA sequence.
Solution Approach 2:
The patent employs transient CRISPR components (Cas9 protein and guide RNA) that are introduced temporarily and do not integrate into the genome, unlike lentiviral vectors. These components perform their function and are then degraded, leaving no permanent foreign genetic material in the cells, thus improving safety while achieving the desired differentiation effect.
2Device complexity
If endpoint analyses are used for monitoring differentiation, then process simplicity is maintained, but real-time monitoring capability is lost
Solution Approach 1:
The patent implements a feedback mechanism by using single-cell RNA sequencing to monitor the differentiation process in real-time. This allows researchers to track cellular transitions, assess differentiation efficiency at multiple time points, and make informed adjustments to the protocol based on actual cellular state information, rather than relying solely on endpoint analyses.
3Manufacturing precision
If genetic manipulation methods are used for RGC differentiation, then differentiation precision is improved, but genome integrity concerns increase
Solution Approach 1:
The patent uses transient CRISPR components that do not integrate into the genome. The Cas9 protein and guide RNA are introduced temporarily, perform their function of knocking out the LINC000093 sequence, and then are degraded without leaving permanent foreign genetic material. This approach achieves precise differentiation control while minimizing concerns about long-term genome integrity and stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the efficiency and safety of RGC differentiation, providing high-quality cells suitable for research and clinical applications by ensuring precise control and real-time monitoring of the differentiation process.
Implementation Method 1
deleting a sequence encoding a long non-coding RNA, LNC000093, having a sequence of SEQ ID NO: 03 from the genome of iPSCs
Data Source
AI summary
A method for differentiating induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) involves deleting a sequence encoding LNC000093 long non-coding RNA from the iPSC genome, culturing the modified iPSCs to generate colonies, and dissociating these colonies to form embryoid bodies. The embryoid bodies are transferred to a first plate to induce neural rosette formation. The neural rosettes are detached and cultured in suspension to develop into neurospheres, which are subsequently transferred to a second plate to promote differentiation into RGCs.